Iron availability, oxygen limitation, Pseudomonas aeruginosa and cystic fibrosis

References

1. Anwar H., Dasgupta M., Lam K., Costerton J. W. 1989; Tobramycin resistance of mucoid Pseudomonas aeruginosa biofilm grown under iron limitation. J Antimicrob Chemother 24:647–655 [CrossRef]
   [Google Scholar]
2. Brown M. R. W., Anwar H., Lambert P. A. 1984; Evidence that mucoid Pseudomonas aeruginosa in the cystic fibrosis lung grows under iron-restricted conditions. FEMS Microbiol Lett 21:113–117 [CrossRef]
   [Google Scholar]
3. Costerton J. W., Stewart P. S., Greenberg E. P. 1999; Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322 [CrossRef]
   [Google Scholar]
4. Frederick J. R., Elkins J. G., Bollinger N., Hassett D. J., McDermott T. R. 2001; Factors affecting catalase expression in Pseudonomas aeruginosa biofilms and planktonic cells. Appl Environ Microbiol 67:1375–1379 [CrossRef]
   [Google Scholar]
5. Haas B., Kraut J., Marks J., Zanker S. C., Castignetti D. 1991; Siderophore presence in sputa of cystic fibrosis patients. Infect Immun 59:3997–4000
   [Google Scholar]
6. Kim E.-J., Sabra W., Zeng A.-P. 2003; Iron deficiency leads to inhibition of oxygen transfer and enhanced formation of virulence factors in cultures of Pseudomonas aeruginosa PAO1. Microbiology 149:2627–2634 [CrossRef]
   [Google Scholar]
7. Ratledge C., Dover L. G. 2000; Iron metabolism in pathogenic bacteria. Annu Rev Microbiol 54:881–941 [CrossRef]
   [Google Scholar]
8. Reid D. W., Kirov S. M. 2004; Iron, Pseudomonas aeruginosa and cystic fibrosis. Microbiology 150:516 [CrossRef]
   [Google Scholar]
9. Reid D. W., Withers N. J., Francis L., Wilson J. W., Kotsimbos T. C. 2002; Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection. Chest 121:48–54 [CrossRef]
   [Google Scholar]
10. Sabra W., Kim E.-J., Zeng A.-P. 2002; Physiological responses of Pseudomonas aeruginosa PAO1 to oxidative stress in controlled microaerobic and aerobic cultures. Microbiology 148:3195–3202
    [Google Scholar]
11. Scharfman A., Kroczynski H., Carnoy C., Van Brussel E., Lamblin G., Ramphal R., Roussel P. 1996; Adhesion of Pseudomonas aeruginosa to respiratory mucins and expression of mucin-binding proteins are increased by limiting iron during growth. Infect Immun 64:5417–5420
    [Google Scholar]
12. Singh P. K., Schaefer A. L., Parsek M. R., Moninger T. O., Welsh M. J., Greenberg E. P. 2000; Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407:762–764 [CrossRef]
    [Google Scholar]
13. Singh P. K., Parsek M. R., Greenberg E. P., Welsh M. J. 2002; A component of innate immunity prevents bacterial biofilm development. Nature 417:552–555 [CrossRef]
    [Google Scholar]
14. Stites S. W., Walters B., O'Brien-Ladner A. R., Bailey K., Wesselius L. J. 1998; Increased iron and ferritin content of sputum from patients with cystic fibrosis or chronic bronchitis. Chest 114:814–819 [CrossRef]
    [Google Scholar]
15. Stites S. W., Plautz M. W., Bailey K., O'Brien-Ladner A. R., Wesselius L. J. 1999; Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis. Am J Respir Crit Care Med 160:796–801 [CrossRef]
    [Google Scholar]
16. Thompson A. B., Bohling T., Payvandi F., Rennard S. I. 1990; Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J Lab Clin Med 115:148–158
    [Google Scholar]
17. Worlitzsch D., Tarran R., Ulrich M.12 other authors 2002; Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109:317–325 [CrossRef]
    [Google Scholar]
18. Yoon S. S., Hennigan R. F., Hilliard G. M.17 other authors 2002; Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell 3:593–603 [CrossRef]
    [Google Scholar]